Regeneron: Driven by Science

For over 25 years, Regeneron's vision has been to build an innovative company that consistently brings new medicines to patients with serious diseases.

Recent News

Regeneron Announces Upcoming 2016 Investor Conference Presentation

07/18/16

TARRYTOWN, N.Y., July 18, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast a management presentation at the following investor conference: 36th Annual Canaccord Genuity Growth Conference at 11:30 a.m. Eastern Time on Thursday, August 11, 2016               ...

Read more

Upcoming Events

Regeneron Pharmaceuticals Q2 2016 Earnings Conference Call

08/04/16 at 8:30 AM ET

View Event

36th Annual Canaccord Genuity Growth Conference

08/11/16 at 11:30 AM ET

View Event




Close
Form content here please :)